AstraZeneca Acquires All Rights to Orexo's OX-CLI Project
March 17, 2016 at 09:47 AM EDT
Orexo AB (publ) today announced that AstraZeneca (NYSE: AZN) has decided to acquire all rights to the leukotriene C4 synthase inhibitor ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.